Cetirizine hydrochloride is a non-sedating H1-receptor antagonist used in patients whit urticaria and allergic rhinitis. It is frequently administrated as racemate; although recent data demonstrate that the antihistaminergic activity of the racemate is primarily due to the levo-enantiomer, while dextrocetirizine failed to demonstrate any significant activity. Moreover levocetirizine exhibits a more pharmacokinetic behaviour due to a lower volume of distribution and a slower renal clearance; therefore cetirizine has been recently marked as levo- enantiomer (Xyzal) in Europe. In order to study the simultaneous determination of (+)- and (-)- cetirizine hydrochloride we have developed direct separation methods by HPLC on polysaccharide-based chiral stationary phases. Satisfactory results were achieved on a Chiralcel OD-R column under gradient elution whit a mobile phase of acetonitrile and perchlorate buffer (0.3M; pH 3.30); these conditions allowed the complete enantioseparations (Rs= 1.65) of the analyte in times suitable for routine analyses. Complete separations in short analysis time (Rs= 1.61) were performed on a Chiralcel OD column under isocratic normal phases conditions (85% n-hexane and 15% ethanol, containing 0.15% trifluoroacetic acid). These conditions were applied to the determination of the stability of cetirizine hydrochloride in methanolic solutions and our studies revealed the formation of an achiral and a chiral degradation product. The developed procedures could be of interest for routine analyses and stereoselective investigations.

Direct HPLC enantioseparation of Cetirizine Hydrochloride on polysaccharide-based chiral stationary phases / Rustichelli, Cecilia; Gamberini, Maria Cristina; Baraldi, Cecilia; Ferioli, Valeria; Gamberini, Gianfranco. - STAMPA. - ...:(2005), pp. 97-97. (Intervento presentato al convegno 11th Meeting on Recent Developments in Pharmaceutical Analysis - RDPA 2005 tenutosi a Rimini nel 25 -28 settembre).

Direct HPLC enantioseparation of Cetirizine Hydrochloride on polysaccharide-based chiral stationary phases

RUSTICHELLI, Cecilia;GAMBERINI, Maria Cristina;BARALDI, Cecilia;FERIOLI, Valeria;GAMBERINI, Gianfranco
2005

Abstract

Cetirizine hydrochloride is a non-sedating H1-receptor antagonist used in patients whit urticaria and allergic rhinitis. It is frequently administrated as racemate; although recent data demonstrate that the antihistaminergic activity of the racemate is primarily due to the levo-enantiomer, while dextrocetirizine failed to demonstrate any significant activity. Moreover levocetirizine exhibits a more pharmacokinetic behaviour due to a lower volume of distribution and a slower renal clearance; therefore cetirizine has been recently marked as levo- enantiomer (Xyzal) in Europe. In order to study the simultaneous determination of (+)- and (-)- cetirizine hydrochloride we have developed direct separation methods by HPLC on polysaccharide-based chiral stationary phases. Satisfactory results were achieved on a Chiralcel OD-R column under gradient elution whit a mobile phase of acetonitrile and perchlorate buffer (0.3M; pH 3.30); these conditions allowed the complete enantioseparations (Rs= 1.65) of the analyte in times suitable for routine analyses. Complete separations in short analysis time (Rs= 1.61) were performed on a Chiralcel OD column under isocratic normal phases conditions (85% n-hexane and 15% ethanol, containing 0.15% trifluoroacetic acid). These conditions were applied to the determination of the stability of cetirizine hydrochloride in methanolic solutions and our studies revealed the formation of an achiral and a chiral degradation product. The developed procedures could be of interest for routine analyses and stereoselective investigations.
2005
11th Meeting on Recent Developments in Pharmaceutical Analysis - RDPA 2005
Rimini
25 -28 settembre
Rustichelli, Cecilia; Gamberini, Maria Cristina; Baraldi, Cecilia; Ferioli, Valeria; Gamberini, Gianfranco
Direct HPLC enantioseparation of Cetirizine Hydrochloride on polysaccharide-based chiral stationary phases / Rustichelli, Cecilia; Gamberini, Maria Cristina; Baraldi, Cecilia; Ferioli, Valeria; Gamberini, Gianfranco. - STAMPA. - ...:(2005), pp. 97-97. (Intervento presentato al convegno 11th Meeting on Recent Developments in Pharmaceutical Analysis - RDPA 2005 tenutosi a Rimini nel 25 -28 settembre).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/309522
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact